Canadian Respiratory Journal (Jan 2001)
Nicotine Replacement Combined with a Novel Compound (ProBAN) for Smoking Cessation: A Pilot Study
Abstract
BACKGROUND: Smoking cessation rates with available pharmacological therapies remain suboptimal. Anecdotal observations with a combination of sublingual pralidoxime and ipratropium (ProBAN) suggested that these agents in combination with nicotine gum improved quit rates.